Oramed Pharmaceuticals ORMP
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 2.85 | 105.45 | 2.59 | 0.24 | -5,672 | 10 |
| 2025Q3 | 2.64 | 16.37 | 1.13 | -2,427 | 48 | |
| 2025Q2 | 2.25 | 0.31 | -2,489 | 13 | ||
| 2025Q1 | 2.14 | -0.19 | -4,500 | -8 | ||
| 2024Q4 | 2.42 | 61.13 | 24.22 | -0.26 | -3,595 | -10 |
| 2024Q3 | 2.44 | 4.87 | -0.48 | -3,089 | -20 | |
| 2024Q2 | 2.57 | 10.42 | 0.22 | -3,135 | 9 | |
| 2024Q1 | 2.92 | -139.32 | 23.25 | 0.04 | -2,962 | 2 |
| 2023Q4 | 2.31 | 0.33 | -3,877 | 13 | ||
| 2023Q3 | 2.61 | 117.70 | -0.08 | -2,893 | -3 | |
| 2023Q2 | 3.58 | 288.73 | -0.03 | -3,791 | -1 | |
| 2023Q1 | 2.18 | 144.23 | -0.08 | -5,208 | -3 | |
| 2022Q4 | 12.03 | 123.04 | -0.22 | -9,740 | -10 | |
| 2022Q3 | 6.48 | -0.18 | -8,189 | -7 | ||
| 2022Q2 | 4.58 | 103.16 | -0.27 | -11,417 | -11 | |
| 2022Q1 | 8.65 | 105.08 | -0.27 | -11,252 | -10 | |
| 2021Q3 | 21.98 | 101.73 | -0.22 | -8,060 | -8 | |
| 2021Q2 | 13.38 | -0.21 | -7,410 | -8 | ||
| 2021Q1 | 10.16 | -0.17 | -6,118 | -5 | ||
| 2020Q4 | 4.24 | -0.17 | -4,868 | -5 |